Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2018-10-10 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于第三届董事会第二十六次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting of 特一药业集团股份有限公司. It details the convening of the third board of directors' 26th meeting, the attendance, and the specific decisions made, including changes to the implementation location of a convertible bond investment project and approval of a credit line application. The document is a formal announcement of board meeting decisions, not a full report or financial statement. It fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short (1765 characters), and it is clearly a meeting resolution announcement rather than a full report or regulatory filing. Therefore, the correct classification is MANG with high confidence.
2018-10-10 Chinese
关于变更可转换公司债券部分募投项目实施地点的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding a change in the implementation location of part of the projects funded by a convertible bond issuance. It details the background of the bond issuance, the original and new project locations, reasons for the change, and opinions from the board, independent directors, and the sponsor. The document is relatively short (2935 characters) and does not contain financial statements or detailed financial data. It is an announcement about a change related to capital raised via convertible bonds, specifically about the use of proceeds and project implementation details. This fits best under the category of Capital/Financing Update (CAP), as it relates to updates on company fundraising and use of proceeds from a convertible bond issuance.
2018-10-10 Chinese
2018年第三季度可转换公司债券转股情况公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转换公司债券) of 特一药业集团股份有限公司 for the third quarter of 2018. It details the bond issuance, conversion price adjustments, and the changes in shareholding due to bond conversions during the quarter ending September 30, 2018. The document includes specific financial figures related to bond conversion and share changes but does not contain comprehensive financial statements or a full quarterly report. It is primarily an update on convertible bond conversion and related shareholding changes, which fits best under Capital/Financing Update (CAP). The document length is 2224 characters, which is relatively short but contains substantive financial data about bond conversions and share changes, so it is not merely an announcement of a report but a standalone update on financing activity.
2018-10-08 Chinese
关于使用部分闲置募集资金进行现金管理到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 特一药业集团股份有限公司 regarding the use of idle raised funds for cash management and the redemption upon maturity of such investments. It details specific financial products, amounts, terms, and returns related to cash management activities. The document includes tables with product names, types, issuing entities, amounts, terms, and actual returns. It is a disclosure about the company's cash management activities using idle raised funds, including historical data for the past twelve months. The document is relatively short (4509 characters) and is an announcement of specific financial activities rather than a comprehensive financial report or earnings release. It does not contain full financial statements or detailed financial analysis. It is not a report publication announcement since it contains substantive information about the cash management activities. The content fits best with a Capital/Financing Update (CAP) as it relates to the company's use of raised funds and cash management activities, which are financing-related updates.
2018-09-28 Chinese
关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 特一药业集团股份有限公司 regarding the use of idle raised funds for cash management, including details of matured redemptions and continued cash management activities. It includes specific financial product details, risk disclosures, and compliance with Shenzhen Stock Exchange regulations. The document is a formal announcement about the company's financing activities related to the use of raised funds, not a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion and analysis. The content fits best under Capital/Financing Update (CAP) as it updates on the company's use of capital raised and related cash management activities.
2018-09-27 Chinese
关于控股股东追加股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the additional pledge of shares by a controlling shareholder of the company. It details the number of shares pledged, the pledgee, dates, and the impact on control and financial status. There is no financial data, no report attached or referenced as being published, and no mention of earnings, management changes, or legal proceedings. The content fits the category of a Major Shareholding Notification, as it informs about changes in significant share ownership levels and pledges by a major shareholder.
2018-09-20 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.